Castillo-Mancilla, Jose R <br/><br/>
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  06 2016 
 - 1609-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkw005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Atazanavir Sulfate--administration & dosage<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors<br/>Humans<br/>Male<br/>Middle Aged<br/>Peru<br/>Pharmacogenetics<br/>Polymorphism, Genetic<br/>Retrospective Studies<br/>South Africa<br/>United States<br/>Young Adult